MTAP and urothelial carcinoma: In a recent study on 1,792 analyzable muscle-invasive urothelial carcinomas, we found MTAP deficiency in 24.0% of cases and observed a sensitivity of 98.4% and a specificity of 99.6% for MTAP IHC to detect homozygous 9p21 deletions14.